• 0

Prograf Indirect Purchaser Class Action Settlement

Class Eligibility

You are a member of the class if between Apr. 15, 2008 and Dec. 31, 2010, you purchased or paid for some or all of the purchase price for Prograf and/or its generic equivalent in capsule form, for consumption by yourself or a member of your family in:

  • Arizona
  • California
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Idaho
  • Illinois
  • Iowa
  • Kansas
  • Maine
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Nebraska
  • Nevada
  • New Hampshire
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Rhode Island
  • South Dakota
  • Tennessee
  • Vermont
  • West Virginia
  • Wisconsin

As a Third Party Payor, you are eligible if between Apr. 15, 2008 and Dec. 31, 2010, you purchased or paid for some or all of the purchase price for Prograf and/or its generic equivalent in capsule form, in capsule form for consumption by your members, employees, insureds, participants, or beneficiaries, and not for resale in:

  • Arizona
  • California
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Idaho
  • Illinois
  • Iowa
  • Kansas
  • Maine
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Nebraska
  • Nevada
  • New Hampshire
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Rhode Island
  • South Dakota
  • Tennessee
  • Vermont
  • West Virginia
  • Wisconsin

Estimated Amount

Varies

Proof of Purchase

Yes

Claim Form

Click Here to Complete Your Progaf Antitrust Claim Form

Case Name

In re Prograf Antitrust Litigation
Civil Action No. 1:11-cv-02242-RWZ,
District Court for the District of Massachusetts

Case Summary

According to the lawsuit Astellas violated various state antitrust, unfair competition, consumer protection, and unjust enrichment laws when they filed a bogus citizen petition in September 2007 with the FDA, which delayed the FDA’s approval of generic versions of Prograf.

Astellas continues to deny that the petition delayed the market entry of generic versions of Prograf. but agrees to settle to bring this lawsuit to an end

Settlement Pool

N/A

Settlement Website

Prograf Antitrust Class Action Settlement

Deadline

12/06/2016

Contact



Prograf Indirect Purchaser Settlement

c/o GCG

PO Box 10112

Dublin, OH 43017-3112

844-322-8238

Email: Questions@PrografIndirectPurchaserSettlement.com

close icon